Financhill
Back

Ocular Therapeutix, Inc. Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCUL is experiencing slight selling pressure.

Ocular Therapeutix, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 14.06 Sell
20-day SMA: 13.24 Sell
50-day SMA: 12.2 Buy
200-day SMA: 10.36 Buy
8-day EMA: 13.59 Sell
20-day EMA: 13.29 Sell
50-day EMA: 12.59 Sell
200-day EMA: 10.91 Buy

Ocular Therapeutix, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.48 Buy
Relative Strength Index (14 RSI): 46.08 Sell
Chaikin Money Flow: -2682430 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.49 - 14.39) Sell
Bollinger Bands (100): (11.24 - 13.22) Buy

Ocular Therapeutix, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Ocular Therapeutix, Inc. Stock

Is Ocular Therapeutix, Inc. Stock a Buy?

OCUL Technical Analysis vs Fundamental Analysis

Buy
54
Ocular Therapeutix, Inc. (OCUL) is a Buy

Is Ocular Therapeutix, Inc. a Buy or a Sell?

Ocular Therapeutix, Inc. Stock Info

Market Cap:
2.7B
Price in USD:
12.56
Share Volume:
7M

Ocular Therapeutix, Inc. 52-Week Range

52-Week High:
16.44
52-Week Low:
5.79
Buy
54
Ocular Therapeutix, Inc. (OCUL) is a Buy

Ocular Therapeutix, Inc. Share Price Forecast

Is Ocular Therapeutix, Inc. Stock a Buy?

Fundamental Analysis of Ocular Therapeutix, Inc.

Is Ocular Therapeutix, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.36 per share, and a decrease next year of $0.05 per share.

Technical Analysis of Ocular Therapeutix, Inc.

Should I short Ocular Therapeutix, Inc. stock?

* Ocular Therapeutix, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.